Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / SHS
-
Total 13F shares
-
4,229,422
-
Share change
-
-583,643
-
Total reported value
-
$11,801,975
-
Put/Call ratio
-
610%
-
Price per share
-
$2.79
-
Number of holders
-
23
-
Value change
-
-$1,638,170
-
Number of buys
-
9
-
Number of sells
-
8
Institutional Holders of GALMED PHARMACEUTICALS LTD - SHS (GLMD) as of Q3 2021
As of 30 Sep 2021 GALMED PHARMACEUTICALS LTD - SHS (GLMD) had 23 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 4,229,422 shares of stock of the company.
Largest 10 holders included BVF INC/IL, Ibex Investors LLC, Nantahala Capital Management, LLC, RAYMOND JAMES & ASSOCIATES, P.A.W. CAPITAL CORP, MORGAN STANLEY, SUSQUEHANNA INTERNATIONAL GROUP, LLP, Rockefeller Capital Management L.P., CITADEL ADVISORS LLC, and GEODE CAPITAL MANAGEMENT, LLC.
This table shows 23 institutional shareholders of the security as of 30 Sep 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.